Skip to Main content Skip to Navigation

Analyse mécanistique des traitements de la douleur neuropathique

Abstract : Neuropathic pain is caused by a lesion or a disease of the somatosensory nervous system. Pregabalin, an anticonvulsant, and duloxetine, an antidepressant, are the standard treatments, effective in one-third of patients. A better understanding of their mechanisms of action is a crucial point to improve their tolerance and efficiency. By using a murine model of peripheral neuropathy, we have shown that : 1) pregabalin, whose effect is independent from the opioid system, acts on the peripheral neuroimmune component of pain ; 2) duloxetine acts via two independent mechanisms, one central (descending controls) for an acute treatment and the other peripheral (dorsal root ganglia) for a chronic treatment. In this case, transcriptomic analysis hightlights an inhibition of the neurogenic inflammation. Comparison of duloxetine plasmatic levels in humans and mice suggests a peripheral action in humans.
Complete list of metadatas

Cited literature [430 references]  Display  Hide  Download
Contributor : Abes Star :  Contact
Submitted on : Friday, February 1, 2019 - 11:51:08 AM
Last modification on : Wednesday, October 14, 2020 - 4:10:46 AM
Long-term archiving on: : Thursday, May 2, 2019 - 4:57:59 PM


Version validated by the jury (STAR)


  • HAL Id : tel-02003411, version 1



Mélanie Kremer. Analyse mécanistique des traitements de la douleur neuropathique. Neurobiologie. Université de Strasbourg, 2016. Français. ⟨NNT : 2016STRAJ033⟩. ⟨tel-02003411⟩



Record views


Files downloads